Skip to content

Clinical Performance of Biofinity Toric Versus Air Optix for Astigmatism

A Single-Center Study Comparing the Clinical Performance of Biofinity Toric Versus Air Optix for Astigmatism Over 1 Month of Daily Wear.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01965288
Enrollment
60
Registered
2013-10-18
Start date
2013-09-30
Completion date
2014-05-31
Last updated
2020-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

The aim of this study is to compare the clinical performance of the Biofinity Toric (comfilcon A) contact lens, versus Air Optix for Astigmatism (lotrafilcon B) over 1 month of daily wear.

Detailed description

Single masked, open label, randomized, bilateral, crossover study design comparing comfilcon A against lotrafilcon B lenses over 1 month of daily wear for each study lens. Each subject will be randomized to wear the test lens (comfilcon A) or the control lens (lotrafilcon B) for one month of daily wear before repeating the schedule for the second pair without a washout period.

Interventions

DEVICEcomfilcon A

test lens Pair(comfilcon A) or the control lens Pair(lotrafilcon B)

test lens Pair(comfilcon A) or the control lens Pair(lotrafilcon B)

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

A person is eligible for inclusion in the study if he/she: * Is between 18 and 40 years of age (inclusive) * Has had a self-reported visual exam in the last two years * Is an adapted soft toric contact lens wearer * Has a contact lens spherical prescription between +6.00 to - 10.00 (inclusive) * Have no less than 0.75diopter (D) of astigmatism and no more than 2.25D in both eyes. * Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye. * Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses. * Has clear corneas and no active ocular disease * Has read, understood and signed the information consent letter. * Patient contact lens refraction should fit within the available parameters of the study lenses. * Is willing to comply with the wear schedule (at least 5 days per week, \> 8 hours/day assuming there are no contraindications for doing so). * Is willing to comply with the visit schedule

Exclusion criteria

A person will be excluded from the study if he/she: * Has a contact lens prescription outside the range of the available parameters of the study lenses. * Has a spectacle cylinder less than -0.75D or more than -2.25 D of cylinder in either eye. * Has a history of not achieving comfortable contact lens wear (5 days per week; \> 8 hours/day) * Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye. * Presence of clinically significant (grade 2-4) anterior segment abnormalities * Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear. * Slit lamp findings that would contraindicate contact lens wear such as: * Pathological dry eye or associated findings * Pterygium, pinguecula, or corneal scars within the visual axis * Neovascularization \> 0.75 mm in from of the limbus * Giant papillary conjunctivitis (GCP) worse than grade 1 * Anterior uveitis or iritis (past or present) * Seborrheic eczema, Seborrheic conjunctivitis * History of corneal ulcers or fungal infections * Poor personal hygiene * Has a known history of corneal hypoesthesia (reduced corneal sensitivity) * Has aphakia, keratoconus or a highly irregular cornea. * Has Presbyopia or has dependence on spectacles for near work over the contact lenses. * Has undergone corneal refractive surgery. * Is participating in any other type of eye related clinical or research study.

Design outcomes

Primary

MeasureTime frameDescription
Overall Stability2 weeksAssessment of Lens Fit Performance for overall lens stability. Collected at 2 weeks for each lens. (Excellent or Good.
Lens Orientation Primary GazeDispenseAssessment of Lens Fit Performance for lens orientation in primary position of gaze. Collected at dispense for each lens. (Degree of mislocation relative to lens axis mark.)
Lens Marking VisibilityDispenseAssessment of Lens Fit Performance for lens marking visibility. Collected at dispense for each lens. (1-3, 1=excellent, 2=average, 3=poor)
Lens Stability on BlinkDispenseAssessment of Lens Fit Performance for lens rotational stability on blink. Collected at dispense for each lens. (No rotation and 5-10 degrees rotation from axis location mark)
Lens Stability 5-10 MinDispenseAssessment of Lens Fit Performance for lens to stabilize in 5-10 min. Collected at dispense for each lens. (Varied less than 5 degrees from lens marking location between 5-10 min)
Lens Overall StabilityDispenseAssessment of Lens Fit Performance for overall lens stability. Collected at dispense for each lens. (Excellent or Good)
Rotational Recovery 30/45 DegDispenseAssessment of Lens Fit Performance for lens rotational recovery to original position. Collected at dispense for each lens. Assessed in degree of mislocation relative to original position after manual temporal rotation. (30 deg/10 blinks, 45 deg/60 sec)
Overall Fit AcceptanceDispenseAssessment of Lens Fit Performance for overall lens fit acceptance. Collected at dispense for each lens. Rated perfect or not perfect based on lens fit alone. (0-4; 0=should not be worn, 3=not perfect but OK to dispense, 4=perfect)
Participants Use of Rewetting Drops2 WeeksProportion of subjects using rewetting drops. Collected at 2 weeks for each lens. (Yes, No)
Vision Quality Insertion, During Day, End Day, Night2 weeksParticipant rating of vision quality on insertion, during the day, end of day and night. Collected at 2 weeks wear for each lens. (0-100; 0=extremely poor vision totally blurred, 100=excellent vision totally sharp)
Vision Stability on Insertion, During Day, End Day2 weeksParticipant rating of vision stability on insertion, during the day, end of day. Collected at 2 weeks wear for each lens. (0-100; 0=totally unstable fluctuating/changing, 100=perfectly stable not fluctuating/changing)
Wavefront Aberrations Root Mean Square (RMS) (3mm)2 WeeksAssessment of wavefront aberrations. Collected at 2 weeks for each lens. Wavefront measurement (3mm), Scale in microns (µm).
Wavefront Aberrations RMS (3mm)4 WeeksAssessment of wavefront aberrations. Collected at 4 weeks for each lens. Wavefront measurement (3mm), Scale in microns (µm).
Wavefront Aberrations RMS (5mm)2 WeeksAssessment of wavefront aberrations. Collected at 2 weeks for each lens. Wavefront measurement (5 mm), Scale in microns (µm).
Lens Surface Deposits2 weeksAssessment of lens front surface deposits. Collected at 2 weeks wear for each lens. (Front surface deposits observed, 0-4, 0=clean, 4=deposits ≥0.5)
Overall Sensation of SmoothnessBaselineParticipant rating for overall sensation of smoothness. Collected at baseline for all habitual lenses. (5-point Likert Scale; Excellent, Good, Average, Below Average)
Comfort SatisfactionBaselineParticipant rating for comfort satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)
Dryness SatisfactionBaselineParticipant rating for dryness satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)
Daily and Comfortable Wearing TimeBaselineParticipant rating of lens Daily and Comfortable Wearing Time. Collected at baseline for all habitual lenses. (The hours of average comfortable wearing time and average daily wearing time.)
Comfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionBaselineParticipant rating of lens Comfort, Dryness, Handling, Lens Fit Stability and Vision Satisfaction. Collected at baseline for all habitual lenses. (0-10; Comfort, Lens Fit and Satisfaction / 0=very poor,10=excellent; Dryness / 0=very dry, 10=no dryness; Handling / 0=very difficult, 10=very easy for handling)
Vision Quality Insertion, During Day, End DayBaselineParticipant rating of vision quality on insertion, during the day, end of day. Collected at baseline for all habitual lenses. (0-100; 0=extremely poor vision totally blurred, 100=excellent vision totally sharp)
Vision Stability Insertion, During Day, End DayBaselineParticipant rating of vision stability on insertion, during the day, end of day. Collected at baseline for all habitual lenses. (0-100; 0=totally unstable fluctuating/changing, 100=perfectly stable not fluctuating/changing)
Overall Sensation of MoistnessBaselineParticipant rating for overall sensation of moistness. Collected at baseline for all habitual lenses. (5-point Likert Scale; Excellent, Good, Average, Below Average)
Handling SatisfactionBaselineParticipant rating for handling satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)
Lens Fit SatisfactionBaselineParticipant rating for lens fit satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)
Vision SatisfactionBaselineParticipant rating for vision satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)
Overall SatisfactionBaselineParticipant rating for overall satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)
Comfort Upon Contact Lens InsertionDispenseParticipant rating of comfort upon insertion. Collected at dispense for each lens. (0-10; 10=Can't Feel)
Vision Satisfaction Upon Contact Lens InsertionDispenseParticipant rating of vision satisfaction upon insertion. Collected at dispense for each lens. (0-10; 10= Very Satisfied)
Vision Quality With Contact Lens PrescriptionDispenseParticipant rating of Vision Quality with contact lens prescription. Collected at dispense for each lens. (0-100; 0=extremely poor vision totally blurred, 100=excellent vision totally sharp)
Vision Stability Upon Contact Lens InsertionDispenseParticipant rating of vision stability on insertion. Collected at dispense for each lens. (0-100; 0=extremely poor vision totally blurred, 100=excellent vision totally sharp)
Visual Acuity logMARDispenseAssessment of monocular and binocular high and low contrast visual acuity (VA). Collected at dispense for each lens. logMAR (VA).
CentrationDispenseAssessment of Lens Fit Performance for centration. Collected at dispense for each lens. (Biomicroscopy; centered or slightly decentered)
Corneal CoverageDispenseAssessment of Lens Fit Performance for corneal coverage. Collected at dispense for each lens. Corneal coverage assessed in primary gaze: (yes=full corneal coverage at all times, no=incomplete corneal coverage)
Post Blink MovementDispenseAssessment of Lens Fit Performance for post blink movement. Collected at dispense for each lens. (0-4, 0.5 increments; 0=Insufficient, unacceptable movement, 4= Excessive, unacceptable movement)

Secondary

MeasureTime frameDescription
Bulbar HyperaemiaBaselineAssessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)
Lower Palpebral HyperaemiaBaselineAssessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)
Corneal Stromal HazeBaselineAssessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)
Corneal NeovascularizationBaselineInvestigators' objective assessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)
Corneal InfiltratesBaselineAssessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)
Participant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)2 weeksParticipant preference for their habitual lenses or the first study lenses during the last two weeks with regard to comfort, dryness, handling, vision, lens fit and overall. (Forced choice; habitual, study lenses)
Participant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)2 weeksParticipant preference for their habitual lenses or the first study lenses during the last two weeks with regard to comfort, dryness, handling, vision, lens fit and overall. (Forced choice; habitual, study lenses)
Participants Likelihood of Switching From Habitual Lenses to the Study Lenses4 weeksParticipants likelihood of switching from habitual lenses to either pair of the study lenses when asked; How likely are they to switch from their habitual lenses to either the first study lenses or the second study lenses? Collected at 4 weeks for each study pair. (4 point Likert scale; very likely, likely, unlikely, very unlikely)
Participants Likelihood of Continuing to Wear the Study Lenses.4 weeksParticipants likelihood of continuing to wear either of the pairs of study lenses when asked; How likely are they to continue to wearing either the first study lenses or the second study lenses? Collected at 4 weeks fore each study pair. (4 point Likert scale; very likely, likely, unlikely, very unlikely)
Participant Recommendation of a Study Lens to Friends, Family or Colleagues8 weeksPercentage of participants that answer the question, What study lens they will most likely recommend to friends, family or colleagues? Collected at end of study. (Forced choice; First Study Lenses, Second Study Lenses)
Participant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.8 weeksPercentage of participants that answer the question, How likely are they to recommend either the first pair of study lenses or the second pair of study lenses to friends, family or colleagues? Collected at study end. (4 point Likert scale; very likely, likely, unlikely, very unlikely)
Participant Preference for Their Habitual Lenses or Either of the Study Lenses8 weeksPercentage of participants that answer the question, Which type of study lens they prefer with regard to comfort, dryness, handling, vision, lens fit and overall performance? Collected at study end. (Forced choice; habitual lenses, first study lenses, second study lenses)
Participant Preference for Either of the Study Lenses8 weeksPercentage of participants that answer the question, Which type of study lens they prefer with regard to comfort, dryness, handling, vision, lens fit and overall performance? Collected at study end. (Forced choice; first study lenses, second study lenses, neither)
Limbal HyperaemiaBaselineAssessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Countries

Spain

Participant flow

Recruitment details

Of the 60 subjects enrolled, 60 were fitted with the study lenses and completed the trial (i.e. no discontinuations).This study design considered a single-center, (Optometry Research Group), located at the University of Valencia Spain (target 60 subjects).

Pre-assignment details

All subjects were habitual lens wearers.

Participants by arm

ArmCount
Comfilcon A Then Lotrafilcon B
All subjects attended first visit with habitual lenses and were randomized to a pair of study lenses. All wore the study lenses for a minimum of 8 hours a day, 7 days a week and one month of daily wear before repeating the schedule for the second pair without a washout period.
30
Lotrafilcon B Then Comfilcon A
All subjects attended first visit with habitual lenses and were randomized to a pair of study lenses. All wore the study lenses for a minimum of 8 hours a day, 7 days a week and one month of daily wear before repeating the schedule for the second pair without a washout period.
30
Total60

Baseline characteristics

CharacteristicComfilcon A Then Lotrafilcon BLotrafilcon B Then Comfilcon ATotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants30 Participants60 Participants
Region of Enrollment
Spain
30 participants30 participants60 participants
Sex: Female, Male
Female
16 Participants21 Participants37 Participants
Sex: Female, Male
Male
14 Participants9 Participants23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 600 / 60
serious
Total, serious adverse events
0 / 600 / 60

Outcome results

Primary

Centration

Assessment of Lens Fit Performance for centration. Collected at 2 weeks for each lens. Proportion of contact lenses fitted where centration was centered or slightly decentered. (Biomicroscopy)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCentrationcentered94 percentage of lenses
Overall Study GroupCentrationslightly decentered6 percentage of lenses
Lotrafilcon BCentrationcentered78 percentage of lenses
Lotrafilcon BCentrationslightly decentered22 percentage of lenses
Primary

Centration

Assessment of Lens Fit Performance for centration. Collected at 4 weeks for each lens. Proportion of contact lenses fitted where centration was centered or slightly decentered. (Biomicroscopy)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCentrationcentered93 percentage of lenses
Overall Study GroupCentrationslightly decentered7 percentage of lenses
Lotrafilcon BCentrationcentered81 percentage of lenses
Lotrafilcon BCentrationslightly decentered19 percentage of lenses
Primary

Centration

Assessment of Lens Fit Performance for centration. Collected at dispense for each lens. (Biomicroscopy; centered or slightly decentered)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCentrationcentered94 percentage of lenses
Overall Study GroupCentrationslightly decentered6 percentage of lenses
Lotrafilcon BCentrationcentered79 percentage of lenses
Lotrafilcon BCentrationslightly decentered21 percentage of lenses
Primary

Comfort, Dryness, Handling, Lens Fit Stability, Vision Satisfaction

Participant rating of lens Comfort, Dryness, Handling, Lens Fit Stability and Vision Satisfaction. Collected at baseline for all habitual lenses. (0-10; Comfort, Lens Fit and Satisfaction / 0=very poor,10=excellent; Dryness / 0=very dry, 10=no dryness; Handling / 0=very difficult, 10=very easy for handling)

Time frame: Baseline

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort on Insertion8.0 units on a scaleStandard Deviation 1.3
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort prior to Removal7.7 units on a scaleStandard Deviation 1.6
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort Overall8.0 units on a scaleStandard Deviation 1.6
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness during the Day8.0 units on a scaleStandard Deviation 1.6
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness prior to Removal7.9 units on a scaleStandard Deviation 1.6
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness Overall7.9 units on a scaleStandard Deviation 1.6
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionHandling8.4 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionOverall Lens Fit8.2 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionOverall Vision Satisfaction8.1 units on a scaleStandard Deviation 1.2
Primary

Comfort, Dryness, Handling, Lens Fit Stability, Vision Satisfaction

Participant rating of lens Comfort, Dryness, Handling, Lens Fit Stability and Vision Satisfaction. Collected at 2 weeks wear for each lens. (0-10; Comfort, Lens Fit and Satisfaction / 0=very poor,10=excellent; Dryness / 0=very dry, 10=no dryness; Handling / 0=very difficult, 10=very easy for handling)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort prior to Removal8.7 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness Overall8.7 units on a scaleStandard Deviation 1.3
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness during the Day8.7 units on a scaleStandard Deviation 1.3
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionHandling8.3 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort Overall8.8 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionLens Fit Stability8.8 units on a scaleStandard Deviation 1.2
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness prior to Removal8.6 units on a scaleStandard Deviation 1.5
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionVision Satisfaction8.7 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort on Insertion8.7 units on a scaleStandard Deviation 1.1
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionVision Satisfaction8.0 units on a scaleStandard Deviation 1.5
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort on Insertion7.7 units on a scaleStandard Deviation 1.3
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort prior to Removal7.4 units on a scaleStandard Deviation 1.4
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort Overall7.6 units on a scaleStandard Deviation 1.3
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness during the Day7.6 units on a scaleStandard Deviation 1.4
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness prior to Removal7.5 units on a scaleStandard Deviation 1.5
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness Overall7.5 units on a scaleStandard Deviation 1.5
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionHandling8.0 units on a scaleStandard Deviation 1.6
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionLens Fit Stability8.0 units on a scaleStandard Deviation 1.5
Primary

Comfort, Dryness, Handling, Lens Fit Stability, Vision Satisfaction

Participant rating of lens Comfort, Dryness, Handling, Lens Fit Stability and Vision Satisfaction. Collected at 4 weeks wear for each lens. (0-10; Comfort, Lens Fit and Satisfaction / 0=very poor,10=excellent; Dryness / 0=very dry, 10=no dryness; Handling / 0=very difficult, 10=very easy for handling)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort prior to Removal8.5 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness Overall8.6 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness during the Day8.5 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionHandling8.2 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort Overall8.6 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionLens Fit Stability8.6 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness prior to Removal8.5 units on a scaleStandard Deviation 1.1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionVision Satisfaction8.5 units on a scaleStandard Deviation 1
Overall Study GroupComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort on Insertion8.6 units on a scaleStandard Deviation 1
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionVision Satisfaction7.6 units on a scaleStandard Deviation 1.6
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort on Insertion7.1 units on a scaleStandard Deviation 1.5
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort prior to Removal6.7 units on a scaleStandard Deviation 1.6
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionComfort Overall6.9 units on a scaleStandard Deviation 1.6
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness during the Day7.0 units on a scaleStandard Deviation 1.6
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness prior to Removal7.0 units on a scaleStandard Deviation 1.5
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionDryness Overall7.0 units on a scaleStandard Deviation 1.6
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionHandling7.8 units on a scaleStandard Deviation 1.7
Lotrafilcon BComfort, Dryness, Handling, Lens Fit Stability, Vision SatisfactionLens Fit Stability7.6 units on a scaleStandard Deviation 1.6
Primary

Comfort Satisfaction

Participant rating for comfort satisfaction. Collected at 4 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupComfort SatisfactionSomewhat Dissatisfied5 percentage of participants
Overall Study GroupComfort SatisfactionCompletely Satisfied72 percentage of participants
Overall Study GroupComfort SatisfactionCompletely Dissatisfied0 percentage of participants
Overall Study GroupComfort SatisfactionSomewhat Satisfied23 percentage of participants
Lotrafilcon BComfort SatisfactionCompletely Dissatisfied10 percentage of participants
Lotrafilcon BComfort SatisfactionSomewhat Satisfied37 percentage of participants
Lotrafilcon BComfort SatisfactionSomewhat Dissatisfied27 percentage of participants
Lotrafilcon BComfort SatisfactionCompletely Satisfied27 percentage of participants
Primary

Comfort Satisfaction

Participant rating for comfort satisfaction. Collected at 2 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupComfort SatisfactionSomewhat Satisfied23 percentage of participants
Overall Study GroupComfort SatisfactionCompletely Satisfied72 percentage of participants
Overall Study GroupComfort SatisfactionSomewhat Dissatisfied5 percentage of participants
Overall Study GroupComfort SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BComfort SatisfactionCompletely Dissatisfied2 percentage of participants
Lotrafilcon BComfort SatisfactionSomewhat Dissatisfied28 percentage of participants
Lotrafilcon BComfort SatisfactionCompletely Satisfied25 percentage of participants
Lotrafilcon BComfort SatisfactionSomewhat Satisfied45 percentage of participants
Primary

Comfort Satisfaction

Participant rating for comfort satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Overall Study GroupComfort SatisfactionCompletely Satisfied37 percentage of participants
Overall Study GroupComfort SatisfactionSomewhat Satisfied55 percentage of participants
Overall Study GroupComfort SatisfactionSomewhat Dissatisfied7 percentage of participants
Overall Study GroupComfort SatisfactionCompletely Dissatisfied2 percentage of participants
Primary

Comfort Upon Contact Lens Insertion

Participant rating of comfort upon insertion. Collected at dispense for each lens. (0-10; 10=Can't Feel)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupComfort Upon Contact Lens Insertion9.0 units on a scaleStandard Deviation 0.8
Lotrafilcon BComfort Upon Contact Lens Insertion7.8 units on a scaleStandard Deviation 1.2
Primary

Corneal Coverage

Assessment of Lens Fit Performance for corneal coverage. Collected at 2 weks for each lens. Corneal coverage assessed in primary gaze: (yes=full corneal coverage at all times, no=incomplete corneal coverage)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (NUMBER)
Overall Study GroupCorneal Coverage100 percentage of lenses
Lotrafilcon BCorneal Coverage100 percentage of lenses
Primary

Corneal Coverage

Assessment of Lens Fit Performance for corneal coverage. Collected at 4 weeks for each lens. Corneal coverage assessed in primary gaze: (yes=full corneal coverage at all times, no=incomplete corneal coverage)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (NUMBER)
Overall Study GroupCorneal Coverage100 percentage of lenses
Lotrafilcon BCorneal Coverage100 percentage of lenses
Primary

Corneal Coverage

Assessment of Lens Fit Performance for corneal coverage. Collected at dispense for each lens. Corneal coverage assessed in primary gaze: (yes=full corneal coverage at all times, no=incomplete corneal coverage)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (NUMBER)
Overall Study GroupCorneal Coverage100 percentage of lenses
Lotrafilcon BCorneal Coverage100 percentage of lenses
Primary

Daily and Comfortable Wearing Time

Participant rating of lens Daily and Comfortable Wearing Time. Collected at 2 weeks wear for each lens. (The hours of average comfortable wearing time and average daily wearing time.)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupDaily and Comfortable Wearing Timeaverage comfortable wearing time9.8 hoursStandard Deviation 2.3
Overall Study GroupDaily and Comfortable Wearing Timeaverage daily wearing time10.1 hoursStandard Deviation 2
Lotrafilcon BDaily and Comfortable Wearing Timeaverage daily wearing time10.1 hoursStandard Deviation 1.8
Lotrafilcon BDaily and Comfortable Wearing Timeaverage comfortable wearing time8.3 hoursStandard Deviation 3
Primary

Daily and Comfortable Wearing Time

Participant rating of lens Daily and Comfortable Wearing Time. Collected at baseline for all habitual lenses. (The hours of average comfortable wearing time and average daily wearing time.)

Time frame: Baseline

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupDaily and Comfortable Wearing TimeAverage comfortable wearing time8.8 hoursStandard Deviation 2.5
Overall Study GroupDaily and Comfortable Wearing TimeAverage daily wearing time9.2 hoursStandard Deviation 2.6
Primary

Daily and Comfortable Wearing Time

Participant rating of lens Daily and Comfortable Wearing Time. Collected at 4 weeks wear for each lens. (The hours of average comfortable wearing time and average daily wearing time.)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupDaily and Comfortable Wearing Timeaverage comfortable wearing time9.5 hoursStandard Deviation 2.1
Overall Study GroupDaily and Comfortable Wearing Timeaverage daily wearing time9.9 hoursStandard Deviation 1.7
Lotrafilcon BDaily and Comfortable Wearing Timeaverage comfortable wearing time7.8 hoursStandard Deviation 2.8
Lotrafilcon BDaily and Comfortable Wearing Timeaverage daily wearing time9.8 hoursStandard Deviation 1.7
Primary

Dryness Satisfaction

Participant rating for dryness satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Overall Study GroupDryness SatisfactionCompletely Satisfied33 percentage of participants
Overall Study GroupDryness SatisfactionSomewhat Satisfied53 percentage of participants
Overall Study GroupDryness SatisfactionSomewhat Dissatisfied12 percentage of participants
Overall Study GroupDryness SatisfactionCompletely Dissatisfied2 percentage of participants
Primary

Dryness Satisfaction

Participant rating for dryness satisfaction. Collected at 4 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupDryness SatisfactionCompletely Satisfied77 percentage of participants
Overall Study GroupDryness SatisfactionSomewhat Satisfied13 percentage of participants
Overall Study GroupDryness SatisfactionSomewhat Dissatisfied10 percentage of participants
Overall Study GroupDryness SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BDryness SatisfactionCompletely Dissatisfied10 percentage of participants
Lotrafilcon BDryness SatisfactionCompletely Satisfied23 percentage of participants
Lotrafilcon BDryness SatisfactionSomewhat Dissatisfied32 percentage of participants
Lotrafilcon BDryness SatisfactionSomewhat Satisfied35 percentage of participants
Primary

Dryness Satisfaction

Participant rating for dryness satisfaction. Collected at 2 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupDryness SatisfactionCompletely Satisfied73 percentage of participants
Overall Study GroupDryness SatisfactionSomewhat Satisfied27 percentage of participants
Overall Study GroupDryness SatisfactionSomewhat Dissatisfied0 percentage of participants
Overall Study GroupDryness SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BDryness SatisfactionCompletely Dissatisfied1.7 percentage of participants
Lotrafilcon BDryness SatisfactionCompletely Satisfied32 percentage of participants
Lotrafilcon BDryness SatisfactionSomewhat Dissatisfied25 percentage of participants
Lotrafilcon BDryness SatisfactionSomewhat Satisfied42 percentage of participants
Primary

Handling Satisfaction

Participant rating for handling satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Overall Study GroupHandling SatisfactionCompletely Satisfied57 percentage of participants
Overall Study GroupHandling SatisfactionSomewhat Satisfied37 percentage of participants
Overall Study GroupHandling SatisfactionSomewhat Dissatisfied5 percentage of participants
Overall Study GroupHandling SatisfactionCompletely Dissatisfied2 percentage of participants
Primary

Handling Satisfaction

Participant rating for handling satisfaction. Collected at 4 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupHandling SatisfactionCompletely Satisfied42 percentage of participants
Overall Study GroupHandling SatisfactionSomewhat Satisfied48 percentage of participants
Overall Study GroupHandling SatisfactionSomewhat Dissatisfied10 percentage of participants
Overall Study GroupHandling SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BHandling SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BHandling SatisfactionCompletely Satisfied40 percentage of participants
Lotrafilcon BHandling SatisfactionSomewhat Dissatisfied12 percentage of participants
Lotrafilcon BHandling SatisfactionSomewhat Satisfied48 percentage of participants
Primary

Handling Satisfaction

Participant rating for handling satisfaction. Collected at 2 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupHandling SatisfactionCompletely Satisfied47 percentage of participants
Overall Study GroupHandling SatisfactionSomewhat Dissatisfied12 percentage of participants
Overall Study GroupHandling SatisfactionSomewhat Satisfied42 percentage of participants
Overall Study GroupHandling SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BHandling SatisfactionSomewhat Satisfied43 percentage of participants
Lotrafilcon BHandling SatisfactionCompletely Satisfied45 percentage of participants
Lotrafilcon BHandling SatisfactionCompletely Dissatisfied1.7 percentage of participants
Lotrafilcon BHandling SatisfactionSomewhat Dissatisfied10 percentage of participants
Primary

Lens Fit Satisfaction

Participant rating for lens fit satisfaction. Collected at 2 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Fit SatisfactionCompletely Satisfied70 percentage of participants
Overall Study GroupLens Fit SatisfactionSomewhat Satisfied27 percentage of participants
Overall Study GroupLens Fit SatisfactionSomewhat Dissatisfied3 percentage of participants
Overall Study GroupLens Fit SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BLens Fit SatisfactionCompletely Dissatisfied2 percentage of participants
Lotrafilcon BLens Fit SatisfactionCompletely Satisfied45 percentage of participants
Lotrafilcon BLens Fit SatisfactionSomewhat Dissatisfied7 percentage of participants
Lotrafilcon BLens Fit SatisfactionSomewhat Satisfied47 percentage of participants
Primary

Lens Fit Satisfaction

Participant rating for lens fit satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Fit SatisfactionCompletely Satisfied42 percentage of participants
Overall Study GroupLens Fit SatisfactionSomewhat Satisfied50 percentage of participants
Overall Study GroupLens Fit SatisfactionSomewhat Dissatisfied8 percentage of participants
Overall Study GroupLens Fit SatisfactionCompletely Dissatisfied0 percentage of participants
Primary

Lens Fit Satisfaction

Participant rating for lens fit satisfaction. Collected at 4 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Fit SatisfactionCompletely Satisfied70 percentage of participants
Overall Study GroupLens Fit SatisfactionSomewhat Dissatisfied5 percentage of participants
Overall Study GroupLens Fit SatisfactionCompletely Dissatisfied0 percentage of participants
Overall Study GroupLens Fit SatisfactionSomewhat Satisfied25 percentage of participants
Lotrafilcon BLens Fit SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BLens Fit SatisfactionCompletely Satisfied35 percentage of participants
Lotrafilcon BLens Fit SatisfactionSomewhat Satisfied55 percentage of participants
Lotrafilcon BLens Fit SatisfactionSomewhat Dissatisfied10 percentage of participants
Primary

Lens Marking Visibility

Assessment of Lens Fit Performance for lens marking visibility. Collected at dispense for each lens. (1-3, 1=excellent, 2=average, 3=poor)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Marking VisibilityExcellent89 percentage of lenses
Overall Study GroupLens Marking VisibilityAverage11 percentage of lenses
Overall Study GroupLens Marking VisibilityPoor0 percentage of lenses
Lotrafilcon BLens Marking VisibilityExcellent42 percentage of lenses
Lotrafilcon BLens Marking VisibilityAverage42 percentage of lenses
Lotrafilcon BLens Marking VisibilityPoor16 percentage of lenses
Primary

Lens Marking Visibility

Assessment of Lens Fit Performance for lens marking visibility. Collected at 2 weeks for each lens. (1-3, 1=excellent, 2=average, 3=poor)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Marking VisibilityExcellent88 percentage of lenses
Overall Study GroupLens Marking VisibilityAverage12 percentage of lenses
Overall Study GroupLens Marking VisibilityPoor0 percentage of lenses
Lotrafilcon BLens Marking VisibilityExcellent27 percentage of lenses
Lotrafilcon BLens Marking VisibilityAverage49 percentage of lenses
Lotrafilcon BLens Marking VisibilityPoor24 percentage of lenses
Primary

Lens Marking Visibility

Assessment of Lens Fit Performance for lens marking visibility. Collected at 4 weeks for each lens. (1-3, 1=excellent, 2=average, 3=poor)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Marking VisibilityExcellent84 percentage of lenses
Overall Study GroupLens Marking VisibilityAverage16 percentage of lenses
Overall Study GroupLens Marking VisibilityPoor0 percentage of lenses
Lotrafilcon BLens Marking VisibilityExcellent20 percentage of lenses
Lotrafilcon BLens Marking VisibilityAverage50 percentage of lenses
Lotrafilcon BLens Marking VisibilityPoor30 percentage of lenses
Primary

Lens Orientation Primary Gaze

Assessment of Lens Fit Performance for lens orientation in primary position of gaze. Collected at dispense for each lens. (Degree of mislocation relative to lens axis mark.)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupLens Orientation Primary Gaze0.71 degreesStandard Deviation 1.75
Lotrafilcon BLens Orientation Primary Gaze1.06 degreesStandard Deviation 1.9
Primary

Lens Orientation Primary Gaze

Assessment of Lens Fit Performance for lens orientation in primary position of gaze. Assessed at 2 weeks wear for each lens. (Degree of mislocation relative to lens axis mark.)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupLens Orientation Primary Gaze0.67 degreesStandard Deviation 1.71
Lotrafilcon BLens Orientation Primary Gaze1.17 degreesStandard Deviation 2.22
Primary

Lens Orientation Primary Gaze

Assessment of Lens Fit Performance for lens orientation in primary position of gaze. Assessed at 4 weeks wear for each lens. (Degree of mislocation relative to lens axis mark.)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupLens Orientation Primary Gaze0.87 degreesStandard Deviation 2.01
Lotrafilcon BLens Orientation Primary Gaze1.08 degreesStandard Deviation 2.17
Primary

Lens Overall Stability

Assessment of Lens Fit Performance for overall lens stability. Collected at dispense for each lens. (Excellent or Good)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Overall StabilityExcellent80 percentage of lenses
Overall Study GroupLens Overall StabilityGood20 percentage of lenses
Lotrafilcon BLens Overall StabilityExcellent50 percentage of lenses
Lotrafilcon BLens Overall StabilityGood50 percentage of lenses
Primary

Lens Stability 5-10 Min

Assessment of Lens Fit Performance for lens to stabilize in 5-10 min. Collected at 4 weeks for each lens. Varied less than 5 degrees from lens marking location between 5-10 min.

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (NUMBER)
Overall Study GroupLens Stability 5-10 Min100 percentage of lenses
Lotrafilcon BLens Stability 5-10 Min100 percentage of lenses
Primary

Lens Stability 5-10 Min

Assessment of Lens Fit Performance for lens to stabilize in 5-10 min. Collected at dispense for each lens. (Varied less than 5 degrees from lens marking location between 5-10 min)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (NUMBER)
Overall Study GroupLens Stability 5-10 Min100 percentage of lenses
Lotrafilcon BLens Stability 5-10 Min100 percentage of lenses
Primary

Lens Stability 5-10 Min

Assessment of Lens Fit Performance for lens to stabilize in 5-10 min. Collected at 2 weeks for each lens. Varied less than 5 degrees from lens marking location between 5-10 min.

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (NUMBER)
Overall Study GroupLens Stability 5-10 Min100 percentage of lenses
Lotrafilcon BLens Stability 5-10 Min100 percentage of lenses
Primary

Lens Stability on Blink

Assessment of Lens Fit Performance for lens rotational stability on blink. Collected at dispense for each lens. (No rotation and 5-10 degrees rotation from axis location mark)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Stability on BlinkNo rotation100 percentage of lenses
Overall Study GroupLens Stability on Blink5-10 degrees0 percentage of lenses
Lotrafilcon BLens Stability on BlinkNo rotation98 percentage of lenses
Lotrafilcon BLens Stability on Blink5-10 degrees2 percentage of lenses
Primary

Lens Stability on Blink

Assessment of Lens Fit Performance for lens rotational stability on blink. Collected at 2 weeks for each lens. (No rotation and 5-10 degrees rotation from axis location mark)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Stability on BlinkNo rotation98 percentage of lenses
Overall Study GroupLens Stability on Blink5-10 degrees2 percentage of lenses
Lotrafilcon BLens Stability on BlinkNo rotation99 percentage of lenses
Lotrafilcon BLens Stability on Blink5-10 degrees1 percentage of lenses
Primary

Lens Stability on Blink

Assessment of Lens Fit Performance for lens rotational stability on blink. Collected at 4 weeks for each lens. (No rotation and 5-10 degrees rotation from axis location mark)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLens Stability on BlinkNo rotation100 percentage of lenses
Overall Study GroupLens Stability on Blink5-10 degrees0 percentage of lenses
Lotrafilcon BLens Stability on BlinkNo rotation99 percentage of lenses
Lotrafilcon BLens Stability on Blink5-10 degrees1 percentage of lenses
Primary

Lens Surface Deposits

Assessment of lens front surface deposits. Collected at 2 weeks wear for each lens. (Front surface deposits observed, 0-4, 0=clean, 4=deposits ≥0.5)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupLens Surface Deposits0.26 units on a scaleStandard Deviation 0.31
Lotrafilcon BLens Surface Deposits0.41 units on a scaleStandard Deviation 0.36
Primary

Lens Surface Deposits

Assessment of lens front surface deposits. Collected at 4 weeks wear for each lens. (Front surface deposits observed, 0-4, 0=clean, 4=deposits ≥0.5)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupLens Surface Deposits0.41 units on a scaleStandard Deviation 0.34
Lotrafilcon BLens Surface Deposits0.71 units on a scaleStandard Deviation 0.41
Primary

Overall Fit Acceptance

Assessment of Lens Fit Performance for overall lens fit acceptance. Collected at 2 weeks for each lens. Rated perfect or not perfect based on lens fit alone. (0-4; 0=should not be worn, 3=not perfect but OK to dispense, 4=perfect)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall Fit AcceptancePerfect76 percentage of lenses
Overall Study GroupOverall Fit AcceptanceNot Perfect24 percentage of lenses
Lotrafilcon BOverall Fit AcceptancePerfect49 percentage of lenses
Lotrafilcon BOverall Fit AcceptanceNot Perfect51 percentage of lenses
Primary

Overall Fit Acceptance

Assessment of Lens Fit Performance for overall lens fit acceptance. Collected at dispense for each lens. Rated perfect or not perfect based on lens fit alone. (0-4; 0=should not be worn, 3=not perfect but OK to dispense, 4=perfect)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall Fit AcceptancePerfect82 percentage of lenses fitted
Overall Study GroupOverall Fit AcceptanceNot Perfect18 percentage of lenses fitted
Lotrafilcon BOverall Fit AcceptancePerfect57 percentage of lenses fitted
Lotrafilcon BOverall Fit AcceptanceNot Perfect43 percentage of lenses fitted
Primary

Overall Fit Acceptance

Assessment of Lens Fit Performance for overall lens fit acceptance. Collected at 4 weeks for each lens. Rated perfect or not perfect based on lens fit alone. (0-4; 0=should not be worn, 3=not perfect but OK to dispense, 4=perfect)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall Fit AcceptancePerfect73 percentage of lenses
Overall Study GroupOverall Fit AcceptanceNot Perfect27 percentage of lenses
Lotrafilcon BOverall Fit AcceptancePerfect44 percentage of lenses
Lotrafilcon BOverall Fit AcceptanceNot Perfect56 percentage of lenses
Primary

Overall Satisfaction

Participant rating for overall satisfaction. Collected at 2 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall SatisfactionCompletely Satisfied68 percentage of participants
Overall Study GroupOverall SatisfactionSomewhat Satisfied30 percentage of participants
Overall Study GroupOverall SatisfactionSomewhat Dissatisfied2 percentage of participants
Overall Study GroupOverall SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BOverall SatisfactionCompletely Dissatisfied2 percentage of participants
Lotrafilcon BOverall SatisfactionCompletely Satisfied30 percentage of participants
Lotrafilcon BOverall SatisfactionSomewhat Dissatisfied23 percentage of participants
Lotrafilcon BOverall SatisfactionSomewhat Satisfied45 percentage of participants
Primary

Overall Satisfaction

Participant rating for overall satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall SatisfactionCompletely Satisfied40 percentage of participants
Overall Study GroupOverall SatisfactionSomewhat Satisfied53 percentage of participants
Overall Study GroupOverall SatisfactionSomewhat Dissatisfied7 percentage of participants
Overall Study GroupOverall SatisfactionCompletely Dissatisfied0 percentage of participants
Primary

Overall Satisfaction

Participant rating for overall satisfaction. Collected at 4 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall SatisfactionCompletely Satisfied65 percentage of participants
Overall Study GroupOverall SatisfactionSomewhat Satisfied28 percentage of participants
Overall Study GroupOverall SatisfactionSomewhat Dissatisfied7 percentage of participants
Overall Study GroupOverall SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BOverall SatisfactionCompletely Dissatisfied7 percentage of participants
Lotrafilcon BOverall SatisfactionCompletely Satisfied22 percentage of participants
Lotrafilcon BOverall SatisfactionSomewhat Dissatisfied27 percentage of participants
Lotrafilcon BOverall SatisfactionSomewhat Satisfied45 percentage of participants
Primary

Overall Sensation of Moistness

Participant rating for overall sensation of moistness. Collected at 4 weeks wear for each lens. (5-point Likert Scale; Excellent, Good, Average, Below Average, Poor)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall Sensation of MoistnessGood27 percentage of participants
Overall Study GroupOverall Sensation of MoistnessBelow Average2 percentage of participants
Overall Study GroupOverall Sensation of MoistnessAverage12 percentage of participants
Overall Study GroupOverall Sensation of MoistnessPoor0 percentage of participants
Overall Study GroupOverall Sensation of MoistnessExcellent60 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessPoor3 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessExcellent18 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessGood23 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessAverage30 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessBelow Average25 percentage of participants
Primary

Overall Sensation of Moistness

Participant rating for overall sensation of moistness. Collected at 2 weeks wear for each lens. (5-point Likert Scale; Excellent, Good, Average, Below Average, Poor)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall Sensation of MoistnessGood30 percentage of participants
Overall Study GroupOverall Sensation of MoistnessBelow Average0 percentage of participants
Overall Study GroupOverall Sensation of MoistnessAverage13 percentage of participants
Overall Study GroupOverall Sensation of MoistnessPoor0 percentage of participants
Overall Study GroupOverall Sensation of MoistnessExcellent57 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessPoor5 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessExcellent20 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessGood30 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessAverage33 percentage of participants
Lotrafilcon BOverall Sensation of MoistnessBelow Average12 percentage of participants
Primary

Overall Sensation of Moistness

Participant rating for overall sensation of moistness. Collected at baseline for all habitual lenses. (5-point Likert Scale; Excellent, Good, Average, Below Average)

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall Sensation of MoistnessGood25 percentage of subjects
Overall Study GroupOverall Sensation of MoistnessAverage50 percentage of subjects
Overall Study GroupOverall Sensation of MoistnessBelow Average0 percentage of subjects
Overall Study GroupOverall Sensation of MoistnessExcellent23 percentage of subjects
Overall Study GroupOverall Sensation of MoistnessPoor2 percentage of subjects
Primary

Overall Sensation of Smoothness

Participant rating for overall sensation of smoothness. Collected at 4 weeks wear for each lens. (5-point Likert Scale; Excellent, Good, Average, Below Average, Poor)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall Sensation of SmoothnessGood42 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessBelow Average2 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessAverage10 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessPoor0 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessExcellent47 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessPoor3 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessExcellent13 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessGood38 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessAverage28 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessBelow Average17 percentage of participants
Primary

Overall Sensation of Smoothness

Participant rating for overall sensation of smoothness. Collected at 2 weeks wear for each lens. (5-point Likert Scale; Excellent, Good, Average, Below Average, Poor)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall Sensation of SmoothnessGood38 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessBelow Average0 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessAverage13 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessPoor0 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessExcellent48 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessPoor2 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessExcellent27 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessGood30 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessAverage30 percentage of participants
Lotrafilcon BOverall Sensation of SmoothnessBelow Average12 percentage of participants
Primary

Overall Sensation of Smoothness

Participant rating for overall sensation of smoothness. Collected at baseline for all habitual lenses. (5-point Likert Scale; Excellent, Good, Average, Below Average)

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall Sensation of SmoothnessExcellent27 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessGood33 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessAverage40 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessBelow Average0 percentage of participants
Overall Study GroupOverall Sensation of SmoothnessPoor0 percentage of participants
Primary

Overall Stability

Assessment of Lens Fit Performance for overall lens stability. Collected at 2 weeks for each lens. (Excellent or Good.

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall StabilityExcellent74 percentage of lenses
Overall Study GroupOverall StabilityGood26 percentage of lenses
Lotrafilcon BOverall StabilityExcellent38 percentage of lenses
Lotrafilcon BOverall StabilityGood62 percentage of lenses
Primary

Overall Stability

Assessment of Lens Fit Performance for overall lens stability. Collected at 4 weeks for each lens. (Excellent or Good.

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupOverall StabilityExcellent72 percentage of lenses
Overall Study GroupOverall StabilityGood28 percentage of lenses
Lotrafilcon BOverall StabilityExcellent36 percentage of lenses
Lotrafilcon BOverall StabilityGood64 percentage of lenses
Primary

Participants Use of Rewetting Drops

Proportion of subjects using rewetting drops. Collected at 4 weeks for each lens. (Yes, No)

Time frame: 4 Weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (NUMBER)
Overall Study GroupParticipants Use of Rewetting Drops15 percentage of participants
Lotrafilcon BParticipants Use of Rewetting Drops58 percentage of participants
Primary

Participants Use of Rewetting Drops

Proportion of subjects using rewetting drops. Collected at 2 weeks for each lens. (Yes, No)

Time frame: 2 Weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (NUMBER)
Overall Study GroupParticipants Use of Rewetting Drops7 percentage of participants
Lotrafilcon BParticipants Use of Rewetting Drops50 percentage of participants
Primary

Post Blink Movement

Assessment of Lens Fit Performance for post blink movement. Collected at dispense for each lens. (0-4, 0.5 increments; 0=Insufficient, unacceptable movement, 4= Excessive, unacceptable movement)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupPost Blink Movement0.09 units on a scaleStandard Deviation 0.3
Lotrafilcon BPost Blink Movement0.19 units on a scaleStandard Deviation 0.42
Primary

Post Blink Movement

Assessment of Lens Fit Performance for post blink movement. Collected at 4 weeks for each lens. (0-4, 0.5 increments; 0=Insufficient, unacceptable movement, 4= Excessive, unacceptable movement)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupPost Blink Movement0.01 units on a scaleStandard Deviation 0.09
Lotrafilcon BPost Blink Movement0.05 units on a scaleStandard Deviation 0.22
Primary

Post Blink Movement

Assessment of Lens Fit Performance for post blink movement. Collected at 2 weeks for each lens. (0-4, 0.5 increments; 0=Insufficient, unacceptable movement, 4= Excessive, unacceptable movement)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupPost Blink Movement0 units on a scaleStandard Deviation 0
Lotrafilcon BPost Blink Movement0.05 units on a scaleStandard Deviation 0.22
Primary

Rotational Recovery 30/45 Deg

Assessment of Lens Fit Performance for lens rotational recovery to original position. Collected at dispense for each lens. Assessed in degree of mislocation relative to original position after manual temporal rotation. (30 deg/10 blinks, 45 deg/60 sec)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupRotational Recovery 30/45 Deg30 deg/ 10 blinks0.542 degreesStandard Deviation 1.56
Overall Study GroupRotational Recovery 30/45 Deg45 deg/ 60 sec0.625 degreesStandard Deviation 1.66
Lotrafilcon BRotational Recovery 30/45 Deg45 deg/ 60 sec0.875 degreesStandard Deviation 2.01
Lotrafilcon BRotational Recovery 30/45 Deg30 deg/ 10 blinks0.833 degreesStandard Deviation 1.98
Primary

Rotational Recovery 30/45 Deg

Assessment of Lens Fit Performance for lens rotational recovery to original position. Collected at 2 weeks wear for each lens. Assessed in degree of mislocation relative to original position after manual temporal rotation. (30 deg/10 blinks, 45 deg/60 sec)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupRotational Recovery 30/45 Deg30 deg/ 10 blinks0.25 degreesStandard Deviation 1.09
Overall Study GroupRotational Recovery 30/45 Deg45 deg/ 60 sec0.58 degreesStandard Deviation 1.61
Lotrafilcon BRotational Recovery 30/45 Deg30 deg/ 10 blinks0.83 degreesStandard Deviation 1.98
Lotrafilcon BRotational Recovery 30/45 Deg45 deg/ 60 sec0.96 degreesStandard Deviation 2.08
Primary

Rotational Recovery 30/45 Deg

Assessment of Lens Fit Performance for lens rotational recovery to original position. Collected at 2 weeks wear for each lens. Assessed in degree of mislocation relative to original position after manual temporal rotation. (30 deg/10 blinks, 45 deg/60 sec)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupRotational Recovery 30/45 Deg30 deg/ 10 blinks0.33 degreesStandard Deviation 1.25
Overall Study GroupRotational Recovery 30/45 Deg45 deg/ 60 sec0.45 degreesStandard Deviation 1.45
Lotrafilcon BRotational Recovery 30/45 Deg30 deg/ 10 blinks0.66 degreesStandard Deviation 1.82
Lotrafilcon BRotational Recovery 30/45 Deg45 deg/ 60 sec0.63 degreesStandard Deviation 1.78
Primary

Vision Quality Insertion, During Day, End Day

Participant rating of vision quality on insertion, during the day, end of day. Collected at baseline for all habitual lenses. (0-100; 0=extremely poor vision totally blurred, 100=excellent vision totally sharp)

Time frame: Baseline

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupVision Quality Insertion, During Day, End DayOn Insertion78.5 units on a scaleStandard Deviation 12.4
Overall Study GroupVision Quality Insertion, During Day, End DayDuring the Day82.7 units on a scaleStandard Deviation 13.2
Overall Study GroupVision Quality Insertion, During Day, End DayEnd of Day80.2 units on a scaleStandard Deviation 14.3
Primary

Vision Quality Insertion, During Day, End Day, Night

Participant rating of vision quality on insertion, during the day, end of day and night. Collected at 4 weeks wear for each lens. (0-100; 0=extremely poor vision totally blurred, 100=excellent vision totally sharp)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupVision Quality Insertion, During Day, End Day, NightOn Insertion85 units on a scaleStandard Deviation 10
Overall Study GroupVision Quality Insertion, During Day, End Day, NightDuring the Day88 units on a scaleStandard Deviation 10
Overall Study GroupVision Quality Insertion, During Day, End Day, NightEnd of Day86 units on a scaleStandard Deviation 11
Overall Study GroupVision Quality Insertion, During Day, End Day, NightNight83 units on a scaleStandard Deviation 10
Lotrafilcon BVision Quality Insertion, During Day, End Day, NightNight76 units on a scaleStandard Deviation 12
Lotrafilcon BVision Quality Insertion, During Day, End Day, NightOn Insertion79 units on a scaleStandard Deviation 11
Lotrafilcon BVision Quality Insertion, During Day, End Day, NightEnd of Day80 units on a scaleStandard Deviation 13
Lotrafilcon BVision Quality Insertion, During Day, End Day, NightDuring the Day82 units on a scaleStandard Deviation 13
Primary

Vision Quality Insertion, During Day, End Day, Night

Participant rating of vision quality on insertion, during the day, end of day and night. Collected at 2 weeks wear for each lens. (0-100; 0=extremely poor vision totally blurred, 100=excellent vision totally sharp)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupVision Quality Insertion, During Day, End Day, NightOn Insertion88 units on a scaleStandard Deviation 8
Overall Study GroupVision Quality Insertion, During Day, End Day, NightDuring the Day89 units on a scaleStandard Deviation 9
Overall Study GroupVision Quality Insertion, During Day, End Day, NightEnd of Day87 units on a scaleStandard Deviation 9
Overall Study GroupVision Quality Insertion, During Day, End Day, NightNight84 units on a scaleStandard Deviation 9
Lotrafilcon BVision Quality Insertion, During Day, End Day, NightNight80 units on a scaleStandard Deviation 12
Lotrafilcon BVision Quality Insertion, During Day, End Day, NightOn Insertion84 units on a scaleStandard Deviation 9
Lotrafilcon BVision Quality Insertion, During Day, End Day, NightEnd of Day83 units on a scaleStandard Deviation 11
Lotrafilcon BVision Quality Insertion, During Day, End Day, NightDuring the Day85 units on a scaleStandard Deviation 10
Primary

Vision Quality With Contact Lens Prescription

Participant rating of Vision Quality with contact lens prescription. Collected at dispense for each lens. (0-100; 0=extremely poor vision totally blurred, 100=excellent vision totally sharp)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupVision Quality With Contact Lens Prescription88 units on a scaleStandard Deviation 9.3
Lotrafilcon BVision Quality With Contact Lens Prescription82 units on a scaleStandard Deviation 11.9
Primary

Vision Satisfaction

Participant rating for vision satisfaction. Collected at 4 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupVision SatisfactionCompletely Satisfied63 percentage of participants
Overall Study GroupVision SatisfactionSomewhat Satisfied32 percentage of participants
Overall Study GroupVision SatisfactionSomewhat Dissatisfied5 percentage of participants
Overall Study GroupVision SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BVision SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BVision SatisfactionCompletely Satisfied35 percentage of participants
Lotrafilcon BVision SatisfactionSomewhat Dissatisfied12 percentage of participants
Lotrafilcon BVision SatisfactionSomewhat Satisfied53 percentage of participants
Primary

Vision Satisfaction

Participant rating for vision satisfaction. Collected at baseline for all habitual lenses. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Overall Study GroupVision SatisfactionCompletely Satisfied48 percentage of participants
Overall Study GroupVision SatisfactionSomewhat Satisfied45 percentage of participants
Overall Study GroupVision SatisfactionSomewhat Dissatisfied7 percentage of participants
Overall Study GroupVision SatisfactionCompletely Dissatisfied0 percentage of participants
Primary

Vision Satisfaction

Participant rating for vision satisfaction. Collected at 2 weeks wear for each lens. (4-point Likert Scale; Completely Satisfied, Somewhat Satisfied, Somewhat Dissatisfied, Completely Dissatisfied)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupVision SatisfactionCompletely Satisfied70 percentage of participants
Overall Study GroupVision SatisfactionSomewhat Satisfied30 percentage of participants
Overall Study GroupVision SatisfactionSomewhat Dissatisfied0 percentage of participants
Overall Study GroupVision SatisfactionCompletely Dissatisfied0 percentage of participants
Lotrafilcon BVision SatisfactionCompletely Dissatisfied2 percentage of participants
Lotrafilcon BVision SatisfactionCompletely Satisfied43 percentage of participants
Lotrafilcon BVision SatisfactionSomewhat Dissatisfied7 percentage of participants
Lotrafilcon BVision SatisfactionSomewhat Satisfied48 percentage of participants
Primary

Vision Satisfaction Upon Contact Lens Insertion

Participant rating of vision satisfaction upon insertion. Collected at dispense for each lens. (0-10; 10= Very Satisfied)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupVision Satisfaction Upon Contact Lens Insertion8.8 units on a scaleStandard Deviation 1.1
Lotrafilcon BVision Satisfaction Upon Contact Lens Insertion8.2 units on a scaleStandard Deviation 1.3
Primary

Vision Stability Insertion, During Day, End Day

Participant rating of vision stability on insertion, during the day, end of day. Collected at baseline for all habitual lenses. (0-100; 0=totally unstable fluctuating/changing, 100=perfectly stable not fluctuating/changing)

Time frame: Baseline

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupVision Stability Insertion, During Day, End DayOn Insertion78.5 units on a scaleStandard Deviation 12
Overall Study GroupVision Stability Insertion, During Day, End DayDuring the Day83.8 units on a scaleStandard Deviation 13.4
Overall Study GroupVision Stability Insertion, During Day, End DayEnd of Day82.9 units on a scaleStandard Deviation 13.3
Primary

Vision Stability on Insertion, During Day, End Day

Participant rating of vision stability on insertion, during the day, end of day. Collected at 2 weeks wear for each lens. (0-100; 0=totally unstable fluctuating/changing, 100=perfectly stable not fluctuating/changing)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupVision Stability on Insertion, During Day, End DayOn Insertion87 units on a scaleStandard Deviation 9
Overall Study GroupVision Stability on Insertion, During Day, End DayDuring the Day91 units on a scaleStandard Deviation 9
Overall Study GroupVision Stability on Insertion, During Day, End DayEnd of Day89 units on a scaleStandard Deviation 10
Lotrafilcon BVision Stability on Insertion, During Day, End DayOn Insertion83 units on a scaleStandard Deviation 11
Lotrafilcon BVision Stability on Insertion, During Day, End DayDuring the Day85 units on a scaleStandard Deviation 13
Lotrafilcon BVision Stability on Insertion, During Day, End DayEnd of Day84 units on a scaleStandard Deviation 12
Primary

Vision Stability on Insertion, During Day, End Day

Participant rating of vision stability on insertion, during the day, end of day. Collected at 4 weeks wear for each lens. (0-100; 0=totally unstable fluctuating/changing, 100=perfectly stable not fluctuating/changing)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupVision Stability on Insertion, During Day, End DayOn Insertion85 units on a scaleStandard Deviation 10
Overall Study GroupVision Stability on Insertion, During Day, End DayDuring the Day87 units on a scaleStandard Deviation 11
Overall Study GroupVision Stability on Insertion, During Day, End DayEnd of Day86 units on a scaleStandard Deviation 9
Lotrafilcon BVision Stability on Insertion, During Day, End DayEnd of Day80 units on a scaleStandard Deviation 13
Lotrafilcon BVision Stability on Insertion, During Day, End DayOn Insertion80 units on a scaleStandard Deviation 13
Lotrafilcon BVision Stability on Insertion, During Day, End DayDuring the Day82 units on a scaleStandard Deviation 14
Primary

Vision Stability Upon Contact Lens Insertion

Participant rating of vision stability on insertion. Collected at dispense for each lens. (0-100; 0=extremely poor vision totally blurred, 100=excellent vision totally sharp)

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (MEAN)Dispersion
Overall Study GroupVision Stability Upon Contact Lens Insertion87 units on a scaleStandard Deviation 11.9
Lotrafilcon BVision Stability Upon Contact Lens Insertion82 units on a scaleStandard Deviation 11.7
Primary

Visual Acuity logMAR

Assessment of monocular and binocular high and low contrast visual acuity (VA). Collected at 2 weeks for each lens. logMAR (VA). Monocular High Contrast Visual Acuity (MHCVA), Monocular Low Contrast Visual Acuity (MLCVA), Binocular High Contrast Visual Acuity (BHCVA), Binocular Low Contrast Visual Acuity (BLCVA)

Time frame: 2 Weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (LOG_MEAN)Dispersion
Overall Study GroupVisual Acuity logMARMHCVA (both eyes Average)-0.01 logMARStandard Deviation 0.05
Overall Study GroupVisual Acuity logMARMLCVA (both eyes Average)0.19 logMARStandard Deviation 0.05
Overall Study GroupVisual Acuity logMARBHCVA-0.04 logMARStandard Deviation 0.05
Overall Study GroupVisual Acuity logMARBLCVA0.17 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARBLCVA0.18 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARMHCVA (both eyes Average)-0.01 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARBHCVA-0.03 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARMLCVA (both eyes Average)0.19 logMARStandard Deviation 0.05
Primary

Visual Acuity logMAR

Assessment of monocular and binocular high and low contrast visual acuity (VA). Collected at 4 weeks for each lens. logMAR (VA). Monocular High Contrast Visual Acuity (MHCVA), Monocular Low Contrast Visual Acuity (MLCVA), Binocular High Contrast Visual Acuity (BHCVA), Binocular Low Contrast Visual Acuity (BLCVA)

Time frame: 4 Weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (LOG_MEAN)Dispersion
Overall Study GroupVisual Acuity logMARMHCVA (both eyes Average)-0.01 logMARStandard Deviation 0.05
Overall Study GroupVisual Acuity logMARMLCVA (both eyes Average)0.19 logMARStandard Deviation 0.05
Overall Study GroupVisual Acuity logMARBHCVA-0.03 logMARStandard Deviation 0.05
Overall Study GroupVisual Acuity logMARBLCVA0.18 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARBLCVA0.18 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARMHCVA (both eyes Average)-0.01 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARBHCVA-0.03 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARMLCVA (both eyes Average)0.19 logMARStandard Deviation 0.05
Primary

Visual Acuity logMAR

Assessment of monocular and binocular high and low contrast visual acuity (VA). Collected at dispense for each lens. logMAR (VA).

Time frame: Dispense

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (LOG_MEAN)Dispersion
Overall Study GroupVisual Acuity logMARMHCVA (OU Average)-0.02 logMARStandard Deviation 0.05
Overall Study GroupVisual Acuity logMARMLCVA (OU Average)0.18 logMARStandard Deviation 0.05
Overall Study GroupVisual Acuity logMARBHCVA-0.04 logMARStandard Deviation 0.06
Overall Study GroupVisual Acuity logMARBLCVA0.17 logMARStandard Deviation 0.07
Lotrafilcon BVisual Acuity logMARBLCVA0.18 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARMHCVA (OU Average)-0.01 logMARStandard Deviation 0.06
Lotrafilcon BVisual Acuity logMARBHCVA-0.02 logMARStandard Deviation 0.05
Lotrafilcon BVisual Acuity logMARMLCVA (OU Average)0.19 logMARStandard Deviation 0.07
Primary

Wavefront Aberrations RMS (3mm)

Assessment of wavefront aberrations. Collected at 4 weeks for each lens. Wavefront measurement (3mm), Scale in microns (µm).

Time frame: 4 Weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupWavefront Aberrations RMS (3mm)HOA0.071 micronsStandard Deviation 0.052
Overall Study GroupWavefront Aberrations RMS (3mm)Third Order0.047 micronsStandard Deviation 0.051
Overall Study GroupWavefront Aberrations RMS (3mm)Fourth Order0.033 micronsStandard Deviation 0.061
Lotrafilcon BWavefront Aberrations RMS (3mm)HOA0.075 micronsStandard Deviation 0.063
Lotrafilcon BWavefront Aberrations RMS (3mm)Third Order0.05 micronsStandard Deviation 0.048
Lotrafilcon BWavefront Aberrations RMS (3mm)Fourth Order0.03 micronsStandard Deviation 0.059
Primary

Wavefront Aberrations RMS (5mm)

Assessment of wavefront aberrations. Collected at 4 weeks for each lens. Wavefront measurement (5 mm), Scale in microns (µm).

Time frame: 4 Weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupWavefront Aberrations RMS (5mm)HOA0.261 micronsStandard Deviation 0.065
Overall Study GroupWavefront Aberrations RMS (5mm)Third Order0.161 micronsStandard Deviation 0.042
Overall Study GroupWavefront Aberrations RMS (5mm)Fourth Order0.075 micronsStandard Deviation 0.0291
Lotrafilcon BWavefront Aberrations RMS (5mm)HOA0.287 micronsStandard Deviation 0.075
Lotrafilcon BWavefront Aberrations RMS (5mm)Third Order0.167 micronsStandard Deviation 0.055
Lotrafilcon BWavefront Aberrations RMS (5mm)Fourth Order0.081 micronsStandard Deviation 0.034
Primary

Wavefront Aberrations RMS (5mm)

Assessment of wavefront aberrations. Collected at 2 weeks for each lens. Wavefront measurement (5 mm), Scale in microns (µm).

Time frame: 2 Weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupWavefront Aberrations RMS (5mm)HOA0.214 micronsStandard Deviation 0.052
Overall Study GroupWavefront Aberrations RMS (5mm)Third Order0.156 micronsStandard Deviation 0.041
Overall Study GroupWavefront Aberrations RMS (5mm)Fourth Order0.071 micronsStandard Deviation 0.031
Lotrafilcon BWavefront Aberrations RMS (5mm)HOA0.223 micronsStandard Deviation 0.063
Lotrafilcon BWavefront Aberrations RMS (5mm)Third Order0.161 micronsStandard Deviation 0.052
Lotrafilcon BWavefront Aberrations RMS (5mm)Fourth Order0.075 micronsStandard Deviation 0.032
Primary

Wavefront Aberrations Root Mean Square (RMS) (3mm)

Assessment of wavefront aberrations. Collected at 2 weeks for each lens. Wavefront measurement (3mm), Scale in microns (µm).

Time frame: 2 Weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Overall Study GroupWavefront Aberrations Root Mean Square (RMS) (3mm)HOA0.065 micronsStandard Deviation 0.061
Overall Study GroupWavefront Aberrations Root Mean Square (RMS) (3mm)Third Order0.043 micronsStandard Deviation 0.054
Overall Study GroupWavefront Aberrations Root Mean Square (RMS) (3mm)Fourth Order0.034 micronsStandard Deviation 0.049
Lotrafilcon BWavefront Aberrations Root Mean Square (RMS) (3mm)Third Order0.046 micronsStandard Deviation 0.041
Lotrafilcon BWavefront Aberrations Root Mean Square (RMS) (3mm)HOA0.07 micronsStandard Deviation 0.066
Lotrafilcon BWavefront Aberrations Root Mean Square (RMS) (3mm)Fourth Order0.029 micronsStandard Deviation 0.051
Secondary

Bulbar Hyperaemia

Assessment of ocular health. Collected at 4 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupBulbar HyperaemiaGrade 0100 percentage of eyes
Overall Study GroupBulbar HyperaemiaGrade 1/20 percentage of eyes
Overall Study GroupBulbar HyperaemiaGrade 10 percentage of eyes
Lotrafilcon BBulbar HyperaemiaGrade 10 percentage of eyes
Lotrafilcon BBulbar HyperaemiaGrade 094 percentage of eyes
Lotrafilcon BBulbar HyperaemiaGrade 1/26 percentage of eyes
Secondary

Bulbar Hyperaemia

Assessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: Baseline

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupBulbar HyperaemiaGrade 1/21.6 percentage of eyes
Overall Study GroupBulbar HyperaemiaGrade 098.4 percentage of eyes
Overall Study GroupBulbar HyperaemiaGrade 10.0 percentage of eyes
Secondary

Bulbar Hyperaemia

Assessment of ocular health. Collected at 2 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupBulbar HyperaemiaGrade 0100 percentage of eyes
Overall Study GroupBulbar HyperaemiaGrade 1/20 percentage of eyes
Overall Study GroupBulbar HyperaemiaGrade 10 percentage of eyes
Lotrafilcon BBulbar HyperaemiaGrade 095 percentage of eyes
Lotrafilcon BBulbar HyperaemiaGrade 1/25 percentage of eyes
Lotrafilcon BBulbar HyperaemiaGrade 10 percentage of eyes
Secondary

Corneal Infiltrates

Assessment of ocular health. Collected at 2 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCorneal InfiltratesGrade 0100 percentage of eyes
Overall Study GroupCorneal InfiltratesGrade 1/20 percentage of eyes
Overall Study GroupCorneal InfiltratesGrade 10 percentage of eyes
Lotrafilcon BCorneal InfiltratesGrade 0100 percentage of eyes
Lotrafilcon BCorneal InfiltratesGrade 1/20 percentage of eyes
Lotrafilcon BCorneal InfiltratesGrade 10 percentage of eyes
Secondary

Corneal Infiltrates

Assessment of ocular health. Collected at 4 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCorneal InfiltratesGrade 0100 percentage of eyes
Overall Study GroupCorneal InfiltratesGrade 1/20 percentage of eyes
Overall Study GroupCorneal InfiltratesGrade 10 percentage of eyes
Lotrafilcon BCorneal InfiltratesGrade 0100 percentage of eyes
Lotrafilcon BCorneal InfiltratesGrade 1/20 percentage of eyes
Lotrafilcon BCorneal InfiltratesGrade 10 percentage of eyes
Secondary

Corneal Infiltrates

Assessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: Baseline

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCorneal InfiltratesGrade 0100 percentage of eyes
Overall Study GroupCorneal InfiltratesGrade 1/20.0 percentage of eyes
Overall Study GroupCorneal InfiltratesGrade 10.0 percentage of eyes
Secondary

Corneal Neovascularization

Investigators' objective assessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: Baseline

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCorneal NeovascularizationGrade 096.7 percentage of eyes
Overall Study GroupCorneal NeovascularizationGrade 1/23.3 percentage of eyes
Overall Study GroupCorneal NeovascularizationGrade 10.0 percentage of eyes
Secondary

Corneal Neovascularization

Assessment of ocular health. Collected at 2 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCorneal NeovascularizationGrade 0100 percentage of eyes
Overall Study GroupCorneal NeovascularizationGrade 1/20 percentage of eyes
Overall Study GroupCorneal NeovascularizationGrade 10 percentage of eyes
Lotrafilcon BCorneal NeovascularizationGrade 096 percentage of eyes
Lotrafilcon BCorneal NeovascularizationGrade 1/24 percentage of eyes
Lotrafilcon BCorneal NeovascularizationGrade 10 percentage of eyes
Secondary

Corneal Neovascularization

Assessment of ocular health. Collected at 4 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCorneal NeovascularizationGrade 0100 percentage of eyes
Overall Study GroupCorneal NeovascularizationGrade 1/20 percentage of eyes
Overall Study GroupCorneal NeovascularizationGrade 10 percentage of eyes
Lotrafilcon BCorneal NeovascularizationGrade 097 percentage of eyes
Lotrafilcon BCorneal NeovascularizationGrade 1/23 percentage of eyes
Lotrafilcon BCorneal NeovascularizationGrade 10 percentage of eyes
Secondary

Corneal Stromal Haze

Assessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: Baseline

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCorneal Stromal HazeGrade 0100 percentage of eyes
Overall Study GroupCorneal Stromal HazeGrade 1/20.0 percentage of eyes
Overall Study GroupCorneal Stromal HazeGrade 10.0 percentage of eyes
Secondary

Corneal Stromal Haze

Assessment of ocular health. Collected at 2 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCorneal Stromal HazeGrade 0100 percentage of eyes
Overall Study GroupCorneal Stromal HazeGrade 1/20 percentage of eyes
Overall Study GroupCorneal Stromal HazeGrade 10 percentage of eyes
Lotrafilcon BCorneal Stromal HazeGrade 0100 percentage of eyes
Lotrafilcon BCorneal Stromal HazeGrade 1/20 percentage of eyes
Lotrafilcon BCorneal Stromal HazeGrade 10 percentage of eyes
Secondary

Corneal Stromal Haze

Assessment of ocular health. Collected at 4 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupCorneal Stromal HazeGrade 0100 percentage of eyes
Overall Study GroupCorneal Stromal HazeGrade 1/20 percentage of eyes
Overall Study GroupCorneal Stromal HazeGrade 10 percentage of eyes
Lotrafilcon BCorneal Stromal HazeGrade 0100 percentage of eyes
Lotrafilcon BCorneal Stromal HazeGrade 1/20 percentage of eyes
Lotrafilcon BCorneal Stromal HazeGrade 10 percentage of eyes
Secondary

Limbal Hyperaemia

Assessment of ocular health. Collected at 2 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLimbal HyperaemiaGrade 10 percentage of eyes
Overall Study GroupLimbal HyperaemiaGrade 099 percentage of eyes
Overall Study GroupLimbal HyperaemiaGrade 1/21 percentage of eyes
Lotrafilcon BLimbal HyperaemiaGrade 10 percentage of eyes
Lotrafilcon BLimbal HyperaemiaGrade 0100 percentage of eyes
Lotrafilcon BLimbal HyperaemiaGrade 1/20 percentage of eyes
Secondary

Limbal Hyperaemia

Assessment of ocular health. Collected at 4 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLimbal HyperaemiaGrade 098 percentage of eyes
Overall Study GroupLimbal HyperaemiaGrade 1/22 percentage of eyes
Overall Study GroupLimbal HyperaemiaGrade 10 percentage of eyes
Lotrafilcon BLimbal HyperaemiaGrade 098 percentage of eyes
Lotrafilcon BLimbal HyperaemiaGrade 1/22 percentage of eyes
Lotrafilcon BLimbal HyperaemiaGrade 10 percentage of eyes
Secondary

Limbal Hyperaemia

Assessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: Baseline

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLimbal HyperaemiaGrade 097.5 percentage of eyes
Overall Study GroupLimbal HyperaemiaGrade 1/22.5 percentage of eyes
Overall Study GroupLimbal HyperaemiaGrade 10.0 percentage of eyes
Secondary

Lower Palpebral Hyperaemia

Assessment of ocular health. Collected at 4 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLower Palpebral HyperaemiaGrade 1/27 percentage of eyes
Overall Study GroupLower Palpebral HyperaemiaGrade 093 percentage of eyes
Overall Study GroupLower Palpebral HyperaemiaGrade 10 percentage of eyes
Lotrafilcon BLower Palpebral HyperaemiaGrade 1/220 percentage of eyes
Lotrafilcon BLower Palpebral HyperaemiaGrade 078 percentage of eyes
Lotrafilcon BLower Palpebral HyperaemiaGrade 12 percentage of eyes
Secondary

Lower Palpebral Hyperaemia

Assessment of ocular health. Collected at baseline after removal of habitual lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: Baseline

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLower Palpebral HyperaemiaGrade 092.5 percentage of eyes
Overall Study GroupLower Palpebral HyperaemiaGrade 1/27.5 percentage of eyes
Overall Study GroupLower Palpebral HyperaemiaGrade 10.0 percentage of eyes
Secondary

Lower Palpebral Hyperaemia

Assessment of ocular health. Collected at 2 weeks after removal of lenses. Proportion of eyes with grades 0-1 (No eyes graded \>1) (Biomicroscopy, 0-4, ½ grades; 0=none: no injection present, 4=severe)

Time frame: 2 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupLower Palpebral HyperaemiaGrade 096 percentage of eyes
Overall Study GroupLower Palpebral HyperaemiaGrade 1/24 percentage of eyes
Overall Study GroupLower Palpebral HyperaemiaGrade 10 percentage of eyes
Lotrafilcon BLower Palpebral HyperaemiaGrade 082 percentage of eyes
Lotrafilcon BLower Palpebral HyperaemiaGrade 1/218 percentage of eyes
Lotrafilcon BLower Palpebral HyperaemiaGrade 10 percentage of eyes
Secondary

Participant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.

Percentage of participants that answer the question, How likely are they to recommend either the first pair of study lenses or the second pair of study lenses to friends, family or colleagues? Collected at study end. (4 point Likert scale; very likely, likely, unlikely, very unlikely)

Time frame: 8 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupParticipant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.Unlikely11 percentage of participants
Overall Study GroupParticipant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.Very Likely52 percentage of participants
Overall Study GroupParticipant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.Very Unlikely2 percentage of participants
Overall Study GroupParticipant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.Likely35 percentage of participants
Lotrafilcon BParticipant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.Very Unlikely10 percentage of participants
Lotrafilcon BParticipant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.Likely40 percentage of participants
Lotrafilcon BParticipant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.Unlikely35 percentage of participants
Lotrafilcon BParticipant Likelihood of Recommending a Study Lens to Friends, Family or Colleagues.Very Likely15 percentage of participants
Secondary

Participant Preference for Either of the Study Lenses

Percentage of participants that answer the question, Which type of study lens they prefer with regard to comfort, dryness, handling, vision, lens fit and overall performance? Collected at study end. (Forced choice; first study lenses, second study lenses, neither)

Time frame: 8 weeks

Population: All 60 subjects wore habitual lenses prior to randomization of study lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupParticipant Preference for Either of the Study LensesOverall78 percentage of participants
Overall Study GroupParticipant Preference for Either of the Study LensesDryness80 percentage of participants
Overall Study GroupParticipant Preference for Either of the Study LensesLens Fit58 percentage of participants
Overall Study GroupParticipant Preference for Either of the Study LensesVision70 percentage of participants
Overall Study GroupParticipant Preference for Either of the Study LensesHandling40 percentage of participants
Overall Study GroupParticipant Preference for Either of the Study LensesComfort80 percentage of participants
Lotrafilcon BParticipant Preference for Either of the Study LensesHandling55 percentage of participants
Lotrafilcon BParticipant Preference for Either of the Study LensesVision28 percentage of participants
Lotrafilcon BParticipant Preference for Either of the Study LensesComfort20 percentage of participants
Lotrafilcon BParticipant Preference for Either of the Study LensesOverall22 percentage of participants
Lotrafilcon BParticipant Preference for Either of the Study LensesLens Fit38 percentage of participants
Lotrafilcon BParticipant Preference for Either of the Study LensesDryness20 percentage of participants
HabitualParticipant Preference for Either of the Study LensesOverall0 percentage of participants
HabitualParticipant Preference for Either of the Study LensesLens Fit4 percentage of participants
HabitualParticipant Preference for Either of the Study LensesComfort0 percentage of participants
HabitualParticipant Preference for Either of the Study LensesDryness0 percentage of participants
HabitualParticipant Preference for Either of the Study LensesHandling5 percentage of participants
HabitualParticipant Preference for Either of the Study LensesVision2 percentage of participants
Secondary

Participant Preference for Their Habitual Lenses or Either of the Study Lenses

Percentage of participants that answer the question, Which type of study lens they prefer with regard to comfort, dryness, handling, vision, lens fit and overall performance? Collected at study end. (Forced choice; habitual lenses, first study lenses, second study lenses)

Time frame: 8 weeks

Population: All 60 subjects wore habitual lenses prior to randomization of study lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupParticipant Preference for Their Habitual Lenses or Either of the Study LensesHandling27 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or Either of the Study LensesComfort72 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or Either of the Study LensesLens Fit47 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or Either of the Study LensesOverall65 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or Either of the Study LensesVision60 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or Either of the Study LensesDryness68 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or Either of the Study LensesDryness17 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or Either of the Study LensesComfort15 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or Either of the Study LensesHandling42 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or Either of the Study LensesLens Fit42 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or Either of the Study LensesVision30 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or Either of the Study LensesOverall23 percentage of participants
HabitualParticipant Preference for Their Habitual Lenses or Either of the Study LensesComfort13 percentage of participants
HabitualParticipant Preference for Their Habitual Lenses or Either of the Study LensesOverall12 percentage of participants
HabitualParticipant Preference for Their Habitual Lenses or Either of the Study LensesVision10 percentage of participants
HabitualParticipant Preference for Their Habitual Lenses or Either of the Study LensesHandling31 percentage of participants
HabitualParticipant Preference for Their Habitual Lenses or Either of the Study LensesDryness15 percentage of participants
HabitualParticipant Preference for Their Habitual Lenses or Either of the Study LensesLens Fit11 percentage of participants
Secondary

Participant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)

Participant preference for their habitual lenses or the first study lenses during the last two weeks with regard to comfort, dryness, handling, vision, lens fit and overall. (Forced choice; habitual, study lenses)

Time frame: 2 weeks

Population: All 60 subjects were habitual lense wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Dryness18 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Vision25 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Comfort20 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Handling55 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Overall25 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Lens Fit30 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Overall75 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Comfort80 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Dryness82 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Handling45 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Vision75 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Lens Fit70 percentage of patients
Secondary

Participant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)

Participant preference for their habitual lenses or the first study lenses during the last four weeks with regard to comfort, dryness, handling, vision, lens fit and overall. (Forced choice; habitual, study lenses)

Time frame: 4 weeks

Population: All 60 subjects were habitual lense wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Comfort20 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Handling52 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Overall23 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Vision27 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Dryness22 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Lens Fit27 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Dryness78 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Overall77 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Comfort80 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Lens Fit73 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Handling48 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Comfilcon A)Vision73 percentage of participants
Secondary

Participant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)

Participant preference for their habitual lenses or the first study lenses during the last four weeks with regard to comfort, dryness, handling, vision, lens fit and overall. (Forced choice; habitual, study lenses)

Time frame: 4 weeks

Population: All 60 subjects were habitual lense wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Vision45 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Dryness58 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Lens Fit52 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Comfort62 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Overall55 percentage of participants
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Handling57 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Overall45 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Comfort38 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Dryness42 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Vision55 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Lens Fit48 percentage of participants
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Handling43 percentage of participants
Secondary

Participant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)

Participant preference for their habitual lenses or the first study lenses during the last two weeks with regard to comfort, dryness, handling, vision, lens fit and overall. (Forced choice; habitual, study lenses)

Time frame: 2 weeks

Population: All 60 subjects were habitual lense wearers and randomized to both sets of study lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Comfort55 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Dryness57 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Handling55 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Vision47 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Lens Fit43 percentage of patients
Overall Study GroupParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Overall53 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Lens Fit57 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Comfort45 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Vision53 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Dryness43 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Overall47 percentage of patients
Lotrafilcon BParticipant Preference for Their Habitual Lenses or the First Study Lenses (Lotrafilcon B)Handling45 percentage of patients
Secondary

Participant Recommendation of a Study Lens to Friends, Family or Colleagues

Percentage of participants that answer the question, What study lens they will most likely recommend to friends, family or colleagues? Collected at end of study. (Forced choice; First Study Lenses, Second Study Lenses)

Time frame: 8 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureValue (NUMBER)
Overall Study GroupParticipant Recommendation of a Study Lens to Friends, Family or Colleagues77 percentage of participants
Lotrafilcon BParticipant Recommendation of a Study Lens to Friends, Family or Colleagues23 percentage of participants
Secondary

Participants Likelihood of Continuing to Wear the Study Lenses.

Participants likelihood of continuing to wear either of the pairs of study lenses when asked; How likely are they to continue to wearing either the first study lenses or the second study lenses? Collected at 4 weeks fore each study pair. (4 point Likert scale; very likely, likely, unlikely, very unlikely)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupParticipants Likelihood of Continuing to Wear the Study Lenses.Very Likely45 percentage of participants
Overall Study GroupParticipants Likelihood of Continuing to Wear the Study Lenses.Likely32 percentage of participants
Overall Study GroupParticipants Likelihood of Continuing to Wear the Study Lenses.Unlikely22 percentage of participants
Overall Study GroupParticipants Likelihood of Continuing to Wear the Study Lenses.Very Unlikely2 percentage of participants
Lotrafilcon BParticipants Likelihood of Continuing to Wear the Study Lenses.Very Unlikely17 percentage of participants
Lotrafilcon BParticipants Likelihood of Continuing to Wear the Study Lenses.Very Likely12 percentage of participants
Lotrafilcon BParticipants Likelihood of Continuing to Wear the Study Lenses.Unlikely42 percentage of participants
Lotrafilcon BParticipants Likelihood of Continuing to Wear the Study Lenses.Likely30 percentage of participants
Secondary

Participants Likelihood of Switching From Habitual Lenses to the Study Lenses

Participants likelihood of switching from habitual lenses to either pair of the study lenses when asked; How likely are they to switch from their habitual lenses to either the first study lenses or the second study lenses? Collected at 4 weeks for each study pair. (4 point Likert scale; very likely, likely, unlikely, very unlikely)

Time frame: 4 weeks

Population: All 60 subjects randomized to both sets of lenses.

ArmMeasureGroupValue (NUMBER)
Overall Study GroupParticipants Likelihood of Switching From Habitual Lenses to the Study LensesVery Likely45 percentage of particpants
Overall Study GroupParticipants Likelihood of Switching From Habitual Lenses to the Study LensesLikely32 percentage of particpants
Overall Study GroupParticipants Likelihood of Switching From Habitual Lenses to the Study LensesUnlikely22 percentage of particpants
Overall Study GroupParticipants Likelihood of Switching From Habitual Lenses to the Study LensesVery Unlikely2 percentage of particpants
Lotrafilcon BParticipants Likelihood of Switching From Habitual Lenses to the Study LensesVery Unlikely17 percentage of particpants
Lotrafilcon BParticipants Likelihood of Switching From Habitual Lenses to the Study LensesVery Likely10 percentage of particpants
Lotrafilcon BParticipants Likelihood of Switching From Habitual Lenses to the Study LensesUnlikely42 percentage of particpants
Lotrafilcon BParticipants Likelihood of Switching From Habitual Lenses to the Study LensesLikely32 percentage of particpants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026